(Q83962653)
Statements
During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4 (English)
Erika Basile
Ebrima Gibbs
Tariq Aziz
scientific article published on 12 June 2006